Cytek Biosciences (CTKB) Is Considered a Good Investment by Brokers: Is That True? [Yahoo! Finance]
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: Yahoo! Finance
Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Cytek Biosciences, Inc. (CTKB). Cytek Biosciences currently has an average brokerage recommendation (ABR) of 1.67, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by six brokerage firms. An ABR of 1.67 approximates between Strong Buy and Buy. Of the six recommendations that derive the current ABR, four are Strong Buy, representing 66.7% of all recommendations. Check price target & stock forecast for Cytek Biosciences here While the ABR calls for buying Cytek Biosciences, it may not be wise to make an investment decision solely based on this information. Several studies have shown limite
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences, Inc. (NASDAQ: CTKB) had its price target lowered by analysts at Piper Sandler from $10.00 to $8.50. They now have an "overweight" rating on the stock.MarketBeat
- Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences Reports First Quarter 2024 Financial ResultsGlobeNewswire
CTKB
Earnings
- 5/8/24 - Miss
CTKB
Sec Filings
- 5/8/24 - Form 10-Q
- 5/8/24 - Form 8-K
- 4/25/24 - Form ARS
- CTKB's page on the SEC website